Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Fifth Eye Inc. logo — FDA cleared software designed to avert crises through early...

Fifth Eye Inc.

FDA cleared software designed to avert crises through early awareness of emerging adverse events.

Founded 2017 United States Ann Arbor, United States 14 employees Series A Total: $13.86M Digital Health, Health Care

General Information

Company Name Fifth Eye Inc.
Founded Year 2017
Location United States Ann Arbor, United States +1
Employees 14
Industries Digital Health, Health Care
Funding Stage Series A
Social

Get notified when Fifth Eye Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Fifth Eye Inc.

Fifth Eye Inc. is a healthcare startup that focuses on averting crises through early awareness of emerging adverse events. The company's flagship product is the AHI System, an FDA-cleared software that predicts episodes of hemodynamic instability with clinically significant lead times, allowing care teams to intervene and avoid costly crises. Founded in 2017 in the United States, the company received a $11.50M Series A investment on 01 April 2019 from investors including Cultivation Capital, Arboretum Ventures, and MINTS. The AHI System, designed for healthcare professionals managing patients over 18 years old, utilizes advanced signal processing, clinician-supervised machine learning, and artificial intelligence to interpret HRV data flow and ECG morphology features, providing crucial insights into patient status. The system's noninvasive nature and ease of adoption make it a valuable addition to hospital telemetry monitoring, enhancing patient care and throughput. Fifth Eye's innovative approach to predictive healthcare technology positions the company as a key player in revolutionizing crisis prevention and patient management.

Taxonomy: FDA-cleared software, medical device software, clinical decision support, artificial intelligence in healthcare, predictive analytics, patient monitoring, hemodynamic instability, predictive modeling, ECG analysis, patient safety, crisis prevention, data-driven healthcare, vital signs monitoring

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 3
Investor Investor
•••• •••• 		01 Apr 2019
Seed Round •••••• 2
Investor Investor
23 Jul 2018

FAQ About Fifth Eye Inc.

FDA cleared software designed to avert crises through early awareness of emerging adverse events.
Fifth Eye Inc. was founded in 2017.
Fifth Eye Inc. is headquartered in Ann Arbor, United States.
Fifth Eye Inc. operates in the following industries: Digital Health, Health Care.
Fifth Eye Inc. has approximately 14 employees.
Fifth Eye Inc. has completed 2 funding rounds, raising a total of $13.86M. The latest funding stage is Series A.

We're actively collecting intelligence on Fifth Eye Inc..

Track Fifth Eye Inc. to get notified

Don't just browse. Track.

Signal Tracker monitors Fifth Eye Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy